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Lipid raftThepast decade,membrane signaling lipids emerged asmajor regulators of ion channel function.However, themo-
lecular nature of lipid binding to ion channels remained poorly described due to a lack of structural information and
assays to quantify andmeasure lipid binding in amembrane. How does a lipid–ligand bind to amembrane protein
in the plasmamembrane, and what does it mean for a lipid to activate or regulate an ion channel? How does lipid
binding compare to activation by soluble neurotransmitter? And how does the cell control lipid agonism? This re-
view focuses on lipids and their interactions with membrane proteins, in particular, ion channels. I discuss the in-
tersection of membrane lipid biology and ion channel biophysics. A picture emerges of membrane lipids as bona
ﬁde agonists of ligand-gated ion channels. These freely diffusing signals reside in the plasma membrane, bind to
the transmembrane domain of protein, and cause a conformational change that allosterically gates an ion channel.
The systememploys a catalog of diverse signaling lipids ultimately controlled by lipid enzymes and raft localization.
I draw upon pharmacology, recent protein structure, and electrophysiological data to understand lipid regulation
and deﬁne inward rectifying potassium channels (Kir) as a new class of PIP2 lipid-gated ion channels.
© 2015 The Author. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Signaling lipids are important regulators of ion channels and exert a
central role in tissue function including functional heartbeat, neuronal
signaling, kidney dialysis, sight, smell, pain, and touch [1–5]. In the
past, most biochemist and ion channel experts viewed lipids as un-
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. This is an open access article underof lipid signaling to ion channels suggested that the formation of anionic
lipids caused a change in the plasma membrane surface charge. Little
was known about how lipids engaged and disengaged the channel or
how the contact of a lipid with protein might affect the conformation
of ion channels in the membrane. A lack of binding constants for lipids
and ion channels challenged our ability to think about lipids as ligands.
Aspects of this problem remain an important hurdle.
In 1998, Hilgemann and colleagues [6] eloquently showed that a sig-
naling lipid could directly activate an ion channel. The lipid, phos-
phatidylinositol 4,5-bisphosphate (PIP2), a minor constituent of the
plasma membrane, was required and sufﬁcient for the activation of a
potassium channel [6]. Despite more than a decade of experimentation,
the nature of PIP2 binding remained clouded by an inability to accurate-
ly measure its concentration in themembrane and directly detect bind-
ing to protein. Simple terminology such as lipid concentration and
afﬁnity are difﬁcult to deﬁne for insoluble molecules in an aqueous en-
vironment [7]. Absent a well-characterized ligand protein interaction,
the initial non-speciﬁc theories of surface charge andmembrane curva-
ture dominated [8,9] but struggled to account for the speciﬁcity of sig-
naling lipids in many systems. Recently, a more accurate model
emerges that includes structural and pharmacological evidence that
lipids bind to and activate ion channels analogous to classic ligand-like
agonist properties [10,11].
Herein, a model of lipid agonism is built on PIP2 and inward rectify-
ing potassium (Kir) channels. Aspects of many other classes of channels
and signaling lipids appear to function in a similar way; select examples
are included throughout this review. The intent of this review is tothe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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membrane lipid biology, although neither ﬁeld is reviewed in a compre-
hensive way.2. The signaling lipid PIP2 is an agonist that gates ion channels
PIP2, arguably the best-studied signaling lipid, is comprised of an
inositol head group (the named feature), a phosphoglycerol backbone,
and two acyl chains (Fig. 1A). PIP2 bears four negative charges and is a
permanent and minor component (b1%) of the Eukaryotic plasma
membrane inner leaﬂet [9,12].2.1. PIP2 ion channel physiology
PIP2 signaling dictates the activatable state of a plethora of ion chan-
nels [2,13,14] (Fig. 1) with broad reaching cellular function. The ﬁrst in-
dication that a channel is PIP2 dependent usually arises when a channel,
excised from the plasmamembrane (e.g., inside out patch), steadily de-
creases in conductance until the channel inactivates. This is known as
“rundown” [2,15]. The excised patch lacks the cytosolic factors to main-
tain sufﬁcient PIP2 levels in the membrane to support ion channel func-
tion; hence, the channels in the patch close. Adding ATP and Mg was
shown to delay rundown [15]. Presumably, PIP2 synthesizing enzymes
are excised in the patchwith the channels and that these enzymeutilize
the ATP to replenish PIP2 [2,15]. Adding back a soluble PIP2 analog
dioctanoyl PIP2 (C8PIP2) rescues activity [2,14] of many ion channel
types [16–19]. In a second method, PIP2 scavengers (e.g., polyamines
or PIP2 antibodies) are used to deplete or mask PIP2 availability [20–
22]. Polyamines are positively charged polymers that bind via avidity
to the multiple negative charges of PIP2. More complete descriptions
of PIP2-dependent ion channels and PIP2 cellular function are reviewed
by Suh and Hille [2,11], Xie [5], and McLaughlin [9]. Recently, a voltage-
sensitive phosphatase (Ci-VSP) was shown to provide direct control
over PIP2 signaling in the membrane [23–25]. When Ci-VSP is co
transfected with Kir [23–25], Kv7.1 [26], Cav2 [27,28], and TRP [29,30],
channels are voltage-dependent consistent with Ci-VSP regulation ofFig. 1. PIP2 lipid regulation of ion channels. (A) The chemical structure of plasmamembrane PIP
position (red). (B) A cartoon representation of a PIP2 lipid-gated ion channel. PIP2 is shown bo
channelswith lipid gating properties. Kir2.2 and 3.2 are themost clearly “lipid gated.”A second g
gating also requires either voltage or a second ligand. A third group of channels behave similar t
exemplary and not comprehensive.PIP2. This method provides better control of PIP2; however, indirect ef-
fects of PIP2 remain a possibility.
In order to directly show PIP2 modulation, an ion channel can be pu-
riﬁed and reconstituted (reinserted) into lipid vesicles with a known
lipid composition. A lack of puriﬁed ion channels limited this technique,
but recent advancements inmembrane protein expression and puriﬁca-
tion [31,32] has overcome this problem for select channel types [33–37].
The nAChRwas among the ﬁrst channels to show direct dependence on
a lipid for activation, phosphatidic acid (PA) [38]. Recently, PIP2-depen-
dent channels were reconstituted into lipid vesicles and shown to re-
spond directly to PIP2 modulation. This includes GIRK [39,40], TRPV1
[41], TRPM8 [42], and Kir2.1-2 [43] channels.
2.2. PIP2 ion channel structure
Despite robust channel modulation by indirect methods, absent a
crystal structure, an understanding of the molecular action of PIP2 and
the precise binding site remained speculative. In 2011, an X-ray crystal
structure complex of Kir2.2 with PIP2 revealed a PIP2 binding site in the
channel's transmembrane domain [10] (Fig. 2). The glycerol backbone
and 1′ phosphate of PIP2 capped the ﬁrst transmembrane spanning
helix (TM1) of Kir. An intimate coordination of the 5′ inositol phosphate
in the distal end of the second transmembrane spanning helix (TM2)
accounted for PIP2 speciﬁcity. Moreover, a conformational change ap-
peared to initiate or open the ion conduction pathway. Basic residues on
a linker between the transmembranedomain and cytoplasmic domaindi-
rectly contacted PIP2, but distal basic residues proposed in the CTD [44]
did not; rather, they were buried and stabilized proper folding of the cy-
toplasmic domain structure [10]. Prior to the Kir2.2/PIP2 complex, struc-
tures of PIP2/protein complexes were limited to soluble membrane
localization domains, which lack a transmembrane domain and share
few if any functional similarities with ion channels. A lack of appropriate
structural examples and an understanding of how lipids and proteins in-
teract in the plasma membrane hindered a complete mechanistic inter-
pretation of PIP2 data. Furthermore, early studies on the C-terminus of
Kir included residues that turned out to be in the TMD of Kir and key to
binding the 5′ inositol phosphate [6] (Fig. 2). Only with recent structural2 is shownwith an arachidonyl acyl chain (green) and inositol phosphates at the 4′ and 5′
und to a lipid-binding site in the transmembrane domain of an ion channel. (C) List of ion
roup appears to be dual regulated, or “PIP2modulated.” PIP2modulates channel gating, but
o Kir but await deﬁnitive proof of lipid gating vs. PIP2 modulation (?). The list of channels is
Fig. 2. Conserved PIP2 binding site in Kir2.2. PIP2 binds the transmembrane domain (TMD) of Kir and causes a conformational change that allosterically gates the channel. (A) The PIP2
binding site is speciﬁc for inositol 5′ phosphate. (B) A sequence alignment of all Kir family members reveals a highly structured PIP2 binding site comprised of basic residues. Amino
acid residues that directly contact PIP2 are shown in bold type. Only two residues (brown type) at the conserved site lack a positive charge. Residues originating from the TMD and a linker
(LNK) are shaded green and gray, respectively. ^ indicates residues that strongly coordinate the lipid backbone phosphate, and * indicates the residues that strongly (red) and weakly
(gray) bind the PIP2 5′ phosphate. PIP2 atoms are colored yellow for carbon, orange for phosphate, and red for oxygen. Amino acid side chains with carbons colored green are located
on transmembrane outer helix 1 (TM1) or inner helix 2 (TM2). Lysines colored gray are located on the start of a linker helix (LNK) or “tether helix” connecting the transmembrane domain
(TMD) and the cytoplasmic domain (CTD). Residue numbering is according to Kir2.2.
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membrane domain of ion channels [10,45–48].
2.3. Lipid-gating theory
Taken together, these ﬁnding suggest a ligand-gating theory of PIP2
activation. In biochemistry, the term ligand refers to the reversible, spe-
ciﬁc, and dose-dependent binding of a substance to a protein to form a
complex. Ligands include small molecule drugs, hormones, peptides,
and metabolites. Normally, ligands stabilize at least two states, one
bound and one unbound [49,50 ].
The binding of PIP2 to Kir has many features of a ligand. First, PIP2 is in
low abundance [9,12]. This requires that PIP2 bindwith high afﬁnity to its
targets to exert an effect. Second, PIP2 binds reversibly to ion channels in a
dose-dependentmanner [19,22]. Third, PIP2 bindswith speciﬁcity; for ex-
ample, PI(4,5)P2 activates Kir2.1 and PI(3,4)P2 inhibits the same channel
[51]. This speciﬁcity is striking since the two lipids are chemical isomers
and only differ in the position of the 5′ phosphate. Another anionic lipid,
oleoyl-CoA, competitively and reversibly inhibits all Kir's [51] except
Katp,which is speciﬁcally activatedbyoleoyl-CoA [52,53]. Fourth, like neu-
rotransmitter, PIP2 is a dynamically regulated molecule [54,55]; a signal-
ing cascade can rapidly change the concentration of PIP2 to cause the
channels to open or close [56–58]. And lastly, PIP2 channel afﬁnity deter-
mines channel function [59]. Mutations that allosterically decrease the af-
ﬁnity of PIP2 cause disease (e.g., the Andersen–Tawil syndrome) [44,60].
The ligand-like characteristics of PIP2 binding to the entire family of
inward rectiﬁers warrant classiﬁcation of these channels as ligand
gated. The unique properties of lipids logically give rise to a lipid sub-
class suggested here “lipid-gated” ion channels.
3. The evolving view of PIP2
3.1. Membrane surface charge theory
PIP2 was ﬁrst speculated to induce ion channel activation by non-
speciﬁc avidity of negatively charged phospholipid binding to clustersof basic amino acids in the C-terminus of channels [2,5,8]. Anionic lipids
were thought to accumulate on the inner leaﬂet and non-speciﬁcally at-
tract positively charged residues on the surface of Kir's cytoplasmic do-
main (CTD). The rational for the theory is sound and was based on
data fromKatp (Kir7.x) [20,61–63] and proteins likeMARCKS [2,8]. How-
ever, in light of the PIP2/Kir complexes, the previous role of electrostatic
theory appears inadequate for Kir. The glycerol backbone of PIP2 bound
tightly to the transmembrane domain (TMD), and the inositol phos-
phates interacted with residues in or proximal to the TMD, not the
CTD. The original inﬂuential lack of Katp's speciﬁcity is an anomaly
among Kir's and appears to be an adaptation that allowed regulation
by oleoyl-CoA [19] and not a mechanistic requirement as speculated. If
non-speciﬁc anionic interactions regulate Kir, the site of anion lipid
binding are likely distal to the canonical PIP2 site [64] or act synergisti-
cally with PIP2 [43,65] by binding to one of the 4 canonical sites. The no-
tion that the cytoplasmic domain is the binding site for PIP2 and that
PIP2 localizes the CTD similar to a PH domain appears to be incorrect.
The Kir2.2 CTD didmove toward themembrane andmay reﬂect an evo-
lutionary origin; but the primarymechanism appears to be an allosteric
conformational change, not non-speciﬁc electrostatic attractions of the
CTD to the membrane surface. The key PIP2 binding interactions were
conﬁrmed in a complex of PIP2 with GIRK2 [47], suggesting a common
mechanism in related Kir channels (Fig. 2B).
Voltage activated ion channels better exemplify non-speciﬁc elec-
trostatic interaction. A well-studied domain called the “voltage sensor
domain” (VSD) senses and responds to changes in surface charge [32,
46,66,67]. Conserved basic residues in the VSD electrostatically move
towards the charge causing a conformational change that gates the
channel (Fig. 3). The charge is non-speciﬁc and can be applied by exter-
nal current or by changing the charge of lipids in the plasmamembrane.
The latter was shown in recent bilayers studies where Kv responded
symmetrically and non-speciﬁcally to anionic lipids [68]. The same
study showed a distinct phosphatidic acid site in the cytoplasmic leaﬂet
that speciﬁcally and dramatically affected Kv gating [68]. This suggests
both ligand and electrostatic modes can operate in the same channel,
however the structural determinants of the two are likely distinct. A
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tative PIP2 speciﬁc binding site [11,69].
Fewother channels currently have sufﬁcientmolecular description to
deﬁnitively discriminate the mechanism of action seen in Kir and Kv.
Many tetrameric channels exhibit a C-terminal charged cluster and vary-
ing degrees of speciﬁcity reminiscent of Kir, including TRP [18,41,70–74],
and P2X4 [75,76] (see Table 1). Typically, these charges immediately fol-
low or are located in the last transmembrane domain. Many other chan-
nels respond to PIP2 in ways that parallel Kir responses, including Cav
[69], NMDA [77], Kv [26], P2X1-3 [78] channels (see also Fig. 1C), but it
is unknown if the interactions are direct with the TMD or indirect
through membrane charge or other proteins. Since numerous soluble
domains use polybasic clusters to target to the plasma membrane [79],
some yet undeﬁned cytoplasmic domains could utilize amembrane sur-
face charge as previously speculated [2,8]. Future structural studies will
continue to reveal the details and breadth of electrostatic theory.
3.2. Cofactor theory
Lipids are sometimes viewed as cofactors. Before discussing PIP2 as a
cofactor I must ﬁrst deﬁne a cofactor and distinguish it from a ligand.
The term cofactor stems from enzymology and generally refers to a per-
manent organic compound or metal that is required for the enzyme to
function. A cofactor normally derives its function by remaining bound
to a protein. In contrast, a ligand derives its function by binding and dis-
sociating from its partner protein. Lipids have always existed in cells and
it is reasonable to assume that some lipidsmay bind as cofactors. A crys-
tal structure of Kv in a lipid like environment revealed phospholipid-
binding sites near the voltage sensor and some of these appear to be
lipid cofactors [46]. In other words, they facilitate the proper organiza-
tion of the channel, but at present they donot appear to initiate a change
in the channel state by dynamic regulation of the lipid.
In a speculative role, PIP2 was proposed to act as a ‘coincidence de-
tector’ in order to facilitate transport of an inactive channel [2,14,72,
80]. A nascent channel in the endoplasmic reticule (ER), where PIP2 is
scarce, remains inactive until it arrives at the plasma membrane
where an abundance of PIP2 constitutively activates the ion channel.
This ﬁts well a deﬁnition of cofactor in the resting state. Directly demon-
strating the physiological contribution remains a challenge since PIP2 is
dynamically regulated [2]. For example, the PLC hydrolysis of PIP2 in the
plasma membrane inhibits Kir [57,58], a function also consistent with
ligand-like properties.
In another speculative role, PIP2might function as a cofactor in sens-
ing protons. The pKa's of inositol phosphates are around 6.5 and 6.9, an
optimal range for sensingphysiological changes in proton concentration
[81]. The lipid could remain bound and simply supply the metal phos-
phate as a proton sensing cofactor. Ions interacting with lipids were re-
cently shown to regulate a receptor [82]. Acid-sensing ion channels
(ASIC) are likely candidates for such a mechanism since they bind PIP2Fig. 3.Mechanistic comparison of surface charge gating vs. direct lipid gating. (A) Non-speciﬁc
arrow indicates charge drivenmovement. (B) A lipid-gated channel reversibly binds the signalin
from the channel.and sense protons. Alternatively, PIP2may serve as a proton-sensitive li-
gand. An atomic structure is known for ASIC [37], but the role of PIP2 in
channel activation requires further investigation.
Perhaps one reason for a slow adaptation of a “lipid-gating” model
for PIP2 is the fact that the prototypical PIP2-gated channel Kir is active
during the resting state of excitable cells. These channels are often con-
sidered “constitutively active” leak channels. While it is true they allow
potassiumout of the cell during the resting state, the acetylcholine stim-
ulation of M1muscarinic receptor inactivates Kir [57,58]. An early study
on high-afﬁnity Kir2.1 in oocytes showed resistance to ACh inactivation
[59], but later studies in mammalian cells demonstrated robust and
complete inhibition of Kir2.1 through activation of M1 receptor [58].
Thus, the neurotransmitter-induced closure of Kir potassium channels
is presumably synergistic with the opening of calcium, sodium, and
voltage-gated channels and should result in a stronger action potential
or sustained excitability.
4. Cellular regulation of PIP2 agonism
The agonist properties of lipids broaden the cell-signaling role of
PIP2 regulation. Similar to neurotransmitter, the release, degradation,
and localization of PIP2 must govern ion channel function.
4.1. Lipid-mediated localization of PIP2 in the plasma membrane
Phosphoinositides distributes heterogeneously in the plasma mem-
brane [83–85]. Hydrophobicity causes lipids to partition (see Fig. 5). Sat-
urated lipid chains partition into cholesterol-rich lipid rafts, often
referred to as detergent-resistant membranes (DRMs). Lipids with
unsaturation partition into the liquid-disordered phase (Ld). Mass spec
of resting cells indicate that PIP2 is comprised of a polyunsaturated
fatty acyl chain [86–88] and localizes in the Ld region of the membrane
[85]. Quantitative studies of PIP2 suggest close to 85% of PIP2 is polyun-
saturated and 70% comprised of an arachidonyl acyl chain [88]. In con-
trast, PIP3 is primarily comprised of saturated or monounsaturated
lipid acyl chains [87]. Strikingly, arachidonyl PIP3 was not detected in
quiescent cells [87]. Based on standard lipid partitioning, the saturated
PIP3 is likely located in cholesterol rafts. In agreementwith this arrange-
ment, PI3 kinase (the enzyme that generates PIP3 from PIP2) localizes to
lipid rafts [89]. Taken together, these data indicate an acyl chain-based
localization of PIPs in the plasmamembrane. Fig. 4 shows a hypothetical
layout of the quiescent cell based on available, but limited, mass spec,
super resolution imaging, and localization studies [85–88].
4.2. GPCR signaling through lipases
Famously, Gq-coupled GPCRs (guanine nucleotide-coupled recep-
tors) hydrolyze PIP2 through phospholipase C (PLC) activation. G-pro-
tein-mediated PIP2 hydrolysis was known more than 30 years agosurface charge gates an ion channel through a charge sensor domain (blue). The vertical
g lipid PIP2 to allosterically gate the channel. A horizontal arrow indicates PIP2 dissociation
Table 1
Inositol phosphate ion channel speciﬁcity.
Channel PIP2 effect Selectivity over Comments Ref
TRPM8 Activation⁎ PI(3,4)P2 and PIP3 5′ activates, 3′ inhibits [18,42]
TRPV1 Mixed PI(4)P and PIP3 Likely acyl chain dependence [41,70]
TRPM4 Activation PI(4)P and PI(5)P Modest selectivity over PIP3 [74]
P2X4 Activation PIP3 Modest selectivity over PIP3 [76]
TRPML Inhibition PI(3,5)P2 (activation) Direct competition of (3,5) with PI(4,5)P2 [71,72]
Kir2.1,1.1 Activation⁎ PI(3,4)P2 (inhibition) Direct competition of (3,4) with PI(4,5)P2 [19,51]
Kir3 (Girk2/4) Activation⁎ PI(4)P Gbg increases PI(4,5)P2 binding [19]
⁎ PIP2 is known to be necessary and sufﬁcient for channel activation.
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tlemore than a substrate for secondmessenger signaling [91]. This view
is inadequate for Kir channels; PIP2 must also be viewed as an ion chan-
nel activator [3,6] or agonist. Hence, the hydrolysis of PIP2 by M1 mus-
carinic receptors should be viewed as a direct regulatory mechanism
to deplete agonist. PIP2 hydrolysis inactivates both high and low afﬁnity
Kir channels [57,58]. The downstream modulation of Kir by phospha-
tases and kinases appear secondary to this direct PIP2 regulation [6,
92], a rational also supported by the central and highly conserved role
of PIP2 in channel activation as described above (2.5). The PLC regula-
tion of Cav [69], Kir [57], HCN [93], Kv7 [26], K2P [94], and TRP [95,96]
channels (among others) is well documented.
In addition to PLC, GPCR signaling activates phospholipase D [97]
(PLD). PLD produces PA and free choline. PA has emerged as an impor-
tant signaling lipid [98]. PA and PIP2 appear to synergistically activate
Kir [43] and K2P [99] channels; in contrast, the nAChR [38] and some Kv
[68] respond speciﬁcally to PA and not PIP2. A third important class of li-
pases phospholipase A2 (PLA2) also exhibits GPCR regulation [100]. PLA2
hydrolyzes arachidonyl-lipids creating lysophospholipids and arachi-
donic acid. Downstream and second messenger signaling are well stud-
ied for PLA2 and PLC and include the arachidonic cascade and IP3
second messenger signaling respectively. In comparison, the upstream
role of the intact bioactive arachidonyl-phospholipids and PIP2 is much
less understood. Nonetheless, the added role of PIP2 in directly gating
ion channels solidiﬁes a direct route for GPCR regulation of ion channels
independent of downstream kinases and calcium signaling [6,92].
Several ion channels bind G-proteins directly, this role is widely ac-
cepted for the G-protein regulated inward rectiﬁers (GIRK/Kir3.x) and
N-type calcium channels (Cav2) [101]. A trimeric complex of GIRK
with Gβγ (a G-protein) and PIP2 revealed the GIRK/Gβγ interface [39].
And biochemical studies suggest that Gβγ is important for increasing
binding of PIP2 to GIRK [40]. The precise mechanism by which Gβγ en-
hances PIP2 activation needs further clariﬁcation.Fig. 4. Phosphoinositide (PI) partitioning in the plasma membrane. In the absence of a stimulus
sometimes in concentrated lipidmicro domains (dark green) apart from cholesterol-rich lipid ra
enters lipid raftswhere PI3 kinase generates PIP3. A saturated lysoPIP2may also associateswith r
domainswhere they are optimally positioned to remodel the PIP acyl chains and head groups du
lipid-recycling event analogous to recycling of some soluble neurotransmitters. Gray diamond4.3. Protein-mediated localization of lipid modifying enzymes
Lipases localize with ion channels to increase the speed and speciﬁc-
ity of PIP2 channel gating [95,102]. For example, rhodopsin-activated
PLC hydrolyzes PIP2 opening TRPL channels. The colocalization of PLC
with TRPL [95] allows for a fast 20 ms response time [103]. In addition,
TRPM7 directly binds PLC to locally affect channel activation [92]. PLC
functionally colocalizedwith NMDA receptors [77], and the IP3 receptor
co-localizes with PLC to regulate calcium release [104]. PLD lipases
directly localize to ion channels, including TRPM8 [105] and TREK-1
[106]. There are many subtypes of lipases; their diverse regulation and
speciﬁc localization satisﬁes cells with the needed diversity for
signaling.4.4. Transient PIP2 signaling
The partitioning of PIPs and their modifying enzymes appears
primed to deliver dynamic cell signaling. During a signaling event,
G-proteins control PIP kinases, lipases, and phosphatases to degrade
PIP2 signaling. This signaling generates lipid degradation products
(Fig. 5B). For example, it was shown PLC activation generates
arachidonyl-diacyl-glycerol [88]. In addition, PLA2 activation removes
the arachidonyl sn2 acyl chain generating lysoPIP2 [107]. In order to re-
turn to a resting state, degradation products need to be removed from
the membrane and PIP2 resynthesized.
Endocytosis recycles lipid micro domains and lipid rafts after signal-
ing [108]. The late endosome and ER feed back into PIP2 signaling. This
postsynaptic lipid reuptakewould then reset themembrane for another
signaling event analogous to presynaptic neurotransmitter reuptake.
Further studies are needed to understand the temporal and spatial reg-
ulation of PIP2 in vivo in particular during a signaling event. However,
signaling lipids are known to control the ion channel desensitization, arachidonyl-PIP2 (green) localizes in the disordered region of the plasma membrane and
fts (red). Inositol lipids are distributed according to their acyl chains; hence, saturated PIP2
aft like domains. Key signaling enzymes (see colored boxes) appear localized in lipidmicro
ring signaling. Lipid degradation products are found in endocytic vesicles, which suggest a
represents PI3 kinase.
Fig. 5. PIP2 transient signaling. (A) In the proposedmodel, PIP2 dissociates from Kir and diffuses laterally in the plasmamembrane. G-proteins activate lipid-hydrolyzing enzymes that de-
plete PIP2 from the plasmamembrane or laterally redistribute PIP2 into distinct lipidmicro domains (e.g., lipid rafts). Dynamic PIP2 signaling gives rise to a transient inactivation of Kir that
contributes to an action potential. (B) PIP2 degradation products are taken up by endocytosis and PIP2 resynthesis returns the cell to a resting state.
625S.B. Hansen / Biochimica et Biophysica Acta 1851 (2015) 620–628[18], voltage dependence [74], and recovery from inactivation [92], and
these events correlate with ion channel rundown. Lipid regulated de-
sensitization may prove to be a central function of many channel
types. Much more data are needed to build a complete picture.
4.5. Other mechanistic considerations
Lipids localize topically by leaﬂets generating a lipid signal. For ex-
ample, phosphatidylserine (PS) is found on the inner leaﬂet of the plas-
ma membrane. Enzymes known as ﬂippases and ﬂoppases move lipids
between leaﬂets [109]. PS signals by ﬂipping outside the cell [110]. PS is
negatively charged and movement outside the cell has the ability to
change the membrane surface charge from negative inside to negative
outside. Recently, asymmetric changes to the charge of lipids in a bilayer
dramatically shifted the voltagemidpoint potential of a Kv channel [68].
Hence, lipids may “ﬂip” as a rapid mechanism to impose a lipid induced
change on the cell membrane potential, a mechanism that would have
likely preceded a synapse.
In a separatemechanism, lipid acyl transferases (LAT) could signal to
ion channels by changing the unsaturation of a lipid acyl chain. LAT en-
zymes add acyl chains to lipids or move acyl chains between existing
lipids [111]. If a LAT enzyme swaps an arachidonyl acyl chainwith a sat-
urated one, the signaling lipid would most likely translocate to a lipid
raft (Fig. 5). This may simply sequester the signal away from the ion
channel bymoving the lipid into or out of a lipidmicro domain. Alterna-
tively, the translocation could make the lipid available to other modify-
ing enzymes that would then deplete the signal from the membrane.
Alternatively, lipid acyl chainsmay directly contribute to gating of an
ion channel. The acyl chains contain chemical diversity and putative
speciﬁcity could determine the afﬁnity of the lipid for the channel or
cause a speciﬁc conformational change that gates the channel. Hydro-
phobic sites for lipid acyl chains affect PIP2 activation of Cav2.2 [11].
The four identical binding sites in Kir are positioned for PIP2 cooper-
atively and allosteric competition. Tetrameric channels engineered to
have only one binding pocket indicated that one PIP2 molecule is sufﬁ-
cient to activate the channel [65]. In wild-type channels with four bind-
ing sites, PIP2 in combination with PA, PG, or PS dramatically increased
channel conductance. However, absent PIP2, these lipids failed to acti-
vate Kir [43]. A structure of Kir with PA bound showed PA binding to
the canonical PIP2 site [10], a site also compatiblewith PG and PS. In bio-
chemical studies, oleoyl-CoA, an endogenous inhibitor, also competes
directly with PIP2 [51]. Taken together, these studies suggest that in
Kir the lipid-binding site is always occupied, and Kir integrates the sumtotal of the lipid environment in a cooperative way. At least one site
must be occupied by PIP2; the remaining three canonical sites appear
to be available to exert cooperative activation or inhibition through a
rigid conformational change [10] in the CTD. Thus, additional PIP2 bind-
ing events are poised to activate Kir with increasing afﬁnity consistent
with electrophysiology recordings [65].
Lastly, the relative abundance of diet-derived fatty acids may affect
the levels of PIP2 signaling in the plasmamembrane. Cells appear to in-
corporate the relative amounts of saturated and unsaturated fats into
their cell membranes (phospholipids) [112]. It is tempting to speculate
that diets with excess saturated fat would lead to saturated PIP2 signal-
ing, whichmost likely favors PIP3 signaling. Diets with large amounts of
polyunsaturated fats (PUFAs) would lead to more arachidonyl-PIP2 and
more PIP2 signaling. This may account for the positive affect of dietary
PUFAs on heart arrhythmias and insulin resistance since PIP2 channels
(including Kir) are central to both these diseases. Consistent, with this
model, loss of PIP2 channel activation is associated with the disease
states [60]. Similar speculation could be made of chronic pain and per-
haps some cancers. Understanding PIP2 acylation may shed light on
these important medical problems.
5. The future of lipid Ion channel interactions
5.1. Pharmacology of lipids
Better methods are needed for assaying lipid interactions with ion
channels. Most studies rely on crude pharmacological shifts of PIP2
concentrations in biological membranes; this is inadequate. Varying
the concentration of lipids in a liposome is a good step in the right di-
rection. Normally, one describes a ligand in terms of an on and off
rate. Certainly, lipids have an afﬁnity for ion channels, but we lack the
methodology for effectivelymeasuring lipid channel interactions. Better
quantitative lipid-binding assays are needed. Newmass spec techniques
will likely allow for quantitative measurements of lipids in vivo and
in vitro. And there is no doubt lipidomics will continue to ﬁnd ways to
improve the quantitative, temporal, and spatial identiﬁcation of lipids
in a membrane.
5.2. Implications on the plasma membrane
The plasmamembrane holds thousands of lipids with functions that
remain largely a mystery [113]. A catalog of lipid signals appears poised
to exert exquisite regulation on membrane proteins perhaps rivaled
626 S.B. Hansen / Biochimica et Biophysica Acta 1851 (2015) 620–628only byprotein phosphorylation. Certainly, the phosphodiester bonds in
lipids are equally suited for rapid signaling. And lipid acyl chainsmay be
as diverse in function as they are in chemistry. Recognizing low abun-
dant phospholipid signaling molecules as potential ligands for mem-
brane proteins reveals a vast pool of putative effector ligands for
cellular signaling.
6. Concluding remarks
The added role of PIP2 activation presented here takes shape from
the recent crystallographic Kir structures. The non-speciﬁc model of
PIP2 activating Kir is gradually making room for a PIP2 site with speciﬁc-
ity and ligand-like properties. How does a lipid–ligand inﬂuence its
target molecule? It does so just like any other molecule; it binds in a
concentration-dependent manner to a binding site and elicits a con-
formational change in the protein. While in hindsight this seems an
obvious possibility, the plasmamembrane has always been a little mys-
terious [114] and the understanding of membrane proteins slow in
coming. No doubt lipidmodulation of proteins is diversewithmore sur-
prises yet to come.
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